OR WAIT 15 SECS
The Annual FDA/PhUSE Computational Science Symposium, to be held on March 18th and 19th 2013 in
Silver Spring, Maryland, provides the premier forum for industry and FDA to collaborate in the realm of
PhUSE, an independent, non‐profit community of professionals focused around the advancement of clinical
information is proud to co‐sponsor, along with The Food and Drug Administration, the Annual FDA/PhUSE
Computational Science Symposium, to be held on March 18th and 19th 2013 in Silver Spring, Maryland, USA.
The symposium is an opportunity for FDA, the pharmaceutical industry, academia, and other computational
science stakeholders to meet in a collaborative environment.
“The symposium provides a platform for FDA and industry to collaborate with the goal of closing some of the
gaps we face in delivering information to the FDA and solving the challenges FDA deals with during their
review cycle,” says Chris Decker, PhUSE FDA Liaison and Vice President, Life Sciences Practice at d‐Wise.
A vital part of the stakeholder collaboration resulted from the creation of working groups at the annual
symposium in 2012. The working group areas of focus are: Data Quality, Data Standards, Standard Scripts,
Non‐clinical. The 2013 Symposium will provide a venue for these groups to continue their collaborative efforts,
as well as to share the exciting progress that they have made in 2012. Additional projects are being formed to
address increasing challenges to the access and review of data identified since the previous meeting.
Participants are encouraged to submit abstracts for a poster session at the Symposium. Abstracts are due by
January 31st 2013.
The Symposium will be held at the Silver Spring Civic Building at Veterans Plaza.